Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00489411 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

231

Enrollment

OTHER

Sponsor class

Conditions

Neurotoxicity
Pain
Peripheral Neuropathy
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: duloxetine hydrochloride
OTHER: placebo

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]